查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1961007

人工智慧（AI）在远端患者监护市场的应用：市场洞察、竞争格局及至2034年的市场预测

Artificial Intelligence (AI) in Remote Patient Monitoring Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

远端患者监护人工智慧（AI）市场概述

  • 全球远端患者监护人工智慧市场规模预计将从 2025 年的 195.2651 亿美元增长到 2034 年的 131.268 亿美元，展现出强劲且持续的成长势头。
  • 全球远端患者监护人工智慧市场预计在 2026 年至 2034 年的预测期内将以 27.13% 的复合年增长率成长。
  • 人工智慧在远端患者监护市场的主要驱动因素是慢性病日益普遍、远端医疗和数位医疗保健解决方案的日益普及、可穿戴和基于物联网的医疗设备的进步，以及製药公司和医疗设备製造商之间日益增多的研究合作和伙伴关係活动。
  • 远端患者监护人工智慧市场的主要企业包括美敦力、iRhythm Inc.、英国皇家飞利浦、西门子医疗、GE医疗、苹果、alivecor Inc.、Biofourmis、Optum, Inc.、Headspace Health、Withings、NeuroRPM Inc.、Caretaker Medical、Implicity、Headspace Health、Withings、NeuroRPM Inc.、Caretaker Medical、Implicity、Skerspace Healths、Zkerpa、Caipa.Atry、Atrys、Spaypa.Atry、Caipa.
  • 预计到2025年，北美地区将引领全球人工智慧远端患者监护市场。这一主导地位归功于几个关键因素，包括癌症和心血管疾病等慢性病的日益增多、完善的医疗基础设施、数位医疗技术的广泛应用以及政府的支持性政策。此外，对数位医疗的大量投资，以及可穿戴和互联医疗设备的日益普及，预计将进一步增强该地区采用人工智慧远端患者监护解决方案的能力，从而推动北美人工智慧远端患者监护市场在2026年至2034年预测期内的成长。
  • 在远端患者监护人工智慧市场的产品类型细分市场中，预计到 2025 年，设备类别将占据最大的市场份额。

推动人工智慧（AI）在远端患者监护市场成长的因素

  • 慢性病发病率上升推动人工智慧在远端患者监护中的应用：糖尿病、心血管疾病、高血压和慢性阻塞性肺病等慢性疾病在全球范围内日益加重，是人工智慧在远距患者监护领域应用的主要驱动力。人工智慧演算法的持续监测能够及早发现併发症并进行主动疾病管理。人工智慧模型分析大量健康数据，预测病情加重和医疗紧急情况，进而减少患者再次入院，改善治疗效果。
  • 远端医疗和数位医疗解决方案的普及：受新冠疫情的进一步加速，远端医疗和虚拟照护的普及显着促进了人工智慧在远距病患监护（RPM）中的应用。人工智慧技术透过提供即时患者分析、自动警报和远距离诊断，增强了远端医疗平台的功能。这种整合确保了病人参与的提高，并保证了在传统医院环境之外的医疗服务的连续性。
  • 穿戴式和物联网医疗设备的进步：智慧型穿戴装置和连网健康设备（例如心电图监测仪、血糖值追踪器和生物感测器）的普及，正在产生大量的患者数据。人工智慧在解读这些数据、识别异常模式和提供临床见解方面发挥关键作用。物联网设备的日益精准和经济实惠，使得人工智慧驱动的远端患者监护解决方案更具扩充性。

人工智慧（AI）在远端患者监护市场细分中的应用

本报告全面概​​述了远端患者监护人工智慧 (AI) 市场，重点介绍了关键趋势、成长要素、挑战和机会。报告按产品/服务（设备、软体、服务）、应用（心血管疾病、糖尿病、神经系统疾病等）、最终用户（医院/诊所、诊断中心和居家医疗机构）以及地区进行了详细的市场细分。本报告深入分析了北美、欧洲和亚太地区等主要市场的竞争格局、监管环境和市场动态，并详细介绍了主要行业参与企业和近期产品创新，为企业提供所需数据，以识别市场潜力、制定战略计划，并在快速增长的远端患者监护人工智能市场中把握新机会。

远端患者监护（RPM）中的人工智慧（AI）是指将人工智慧技术整合到远端医疗监护系统中，以便在传统临床环境之外持续追踪、分析和解读患者的健康数据。透过利用机器学习、预测分析和其他人工智慧演算法，这些系统可以检测异常情况、预测潜在的健康风险，并为医疗服务提供者提供即时、可操作的见解。这有助于主动管理慢性疾病、实现个人化照护并改善患者预后，同时减少住院次数和医疗成本。

由于癌症、心血管疾病和文明病等慢性病的发生率不断上升，人工智慧（AI）在远端患者监护（RPM）领域的市场正经历强劲增长。产品研发倡议的激增、全球对数位医疗基础设施投资的增加以及对预防性和数据驱动型医疗保健日益增长的重视，进一步推动了这一增长。预计这些因素将在2026年至2034年的预测期内显着扩张人工智慧驱动的远端患者监护市场。

远端患者监护领域人工智慧（AI）的最新市场动态和趋势

近年来，全球远端患者监护人工智慧市场经历了显着增长，这主要是由于癌症、糖尿病、心血管疾病、呼吸系统疾病等慢性病的盛行率不断上升。此外，製药、生物技术和医疗设备製造商之间策略联盟和伙伴关係的日益增多，也对加速采用人工智慧远端患者监护设备起到了关键作用。

人工智慧（AI）在远端患者监护市场細項分析

人工智慧 (AI) 在远端患者监护市场中的应用，按产品/服务（设备、软体、服务）、应用（心血管疾病、糖尿病、神经系统疾病、其他）、最终用户（医院/诊所、诊断中心、居家医疗机构）和地区（北美、欧洲、亚太地区、世界其他地区）划分。

远端患者监护市场人工智慧（AI）区域分析

北美远端患者监护市场人工智慧（AI）发展趋势

预计2025年，北美将主导人工智慧在临床试验领域的市场，约占全球总量的47%。该地区人工智慧远端患者监护市场的成长受多种因素驱动，包括癌症和心血管疾病等慢性病患病率的上升、完善的医疗基础设施、数位医疗技术的广泛应用以及政府的支持性政策。此外，数位医疗倡议的巨额投资，以及穿戴式和连网医疗设备的日益普及，进一步增强了该地区采用人工智慧远距患者监护解决方案的准备。

根据美国心臟协会（2024年）的数据，美国约有970万成年人患有未确诊的糖尿病。另有1.159亿人被报告为糖尿病前期患者。

此外，美国疾病管制与预防中心（CDC，2024）报告称，美国约有620万成年人患有心臟衰竭。该机构也指出，约有2050万人患有心臟疾病。此外，同年估计有650万40岁及以上的人被诊断出患有周边动脉疾病（PAD）。

慢性疾病患者需要频繁监测血糖值、心率、血压和心电图等参数，而所有这些参数都可以透过整合人工智慧的远端患者管理 (RPM) 设备进行有效追踪。人工智慧演算法分析即时病患数据，侦测异常情况，预测潜在併发症，并及时向医护人员发出警报，从而降低住院率并改善病患预后。例如，人工智慧驱动的连续血糖监测仪 (CGM) 和智慧心臟贴片正在帮助临床医生远端做出明智的治疗决策。随着医疗保健系统向预防性和个人化护理转型，人工智慧驱动的 RPM 解决方案能够对糖尿病和心血管疾病进行持续、预测性和经济高效的管理，这正在推动其普及和整体市场成长。

此外，北美主要的产业参与企业正积极进行产品研发活动。例如，PanopticAI 于 2025 年 1 月获得 FDA核准，其创新的「Vital Signs」应用程式正式上市，这标誌着人工智慧驱动的远端患者监护取得了重大突破。该应用程式作为一款医疗设备(SaMD)，利用 iPhone 和 iPad 的内藏相机，透过远端光电容积脉搏波描记法 (rPPG) 技术提供非接触式脉搏测量。这项突破性技术使用户和医疗保健提供者无需物理接触或佩戴可穿戴设备即可准确测量生命体征，使其成为远端医疗、慢性病管理和远距照护应用的理想选择。 FDA 的核准表明，基于摄影机的人工智慧健康监测工具正日益被接受，提高了病患监测系统的可及性、便利性和扩充性，尤其是在家庭和门诊环境中。

因此，上述所有因素预计将在预测期内（即 2026-2034 年）推动人工智慧在远端患者监护市场实现显着成长。

欧洲远端患者监护市场人工智慧（AI）趋势

受数位化医疗转型、人口老化以及糖尿病、心血管疾病和呼吸系统疾病等慢性病日益增多的推动，欧洲远端患者监护（RPM）人工智慧（AI）市场正经历强劲增长。欧洲医疗系统正在加速采用人工智慧驱动的监护工具，以实现主动式和持续性护理，尤其是在居家医疗和远距远端医疗环境中。欧盟的扶持政策，例如欧盟健康计画（EU4Health）和数位欧洲倡议（Digital Europe），正在推动先进人工智慧技术的应用，以提高医疗效率并减轻医院基础设施的压力。此外，基于人工智慧的RPM解决方案正在帮助医疗服务提供者分析即时患者数据，及早发现病情恶化征兆，并制定个人化治疗方案，从而改善临床疗效并降低成本。

这一趋势的一个显着例证是西门子医疗于2025年7月在欧洲医院部署的人工智慧远端患者监护平台。该平台旨在利用预测分析和持续的数据洞察，及早发现心血管和呼吸系统疾病的征兆。这项进展表明，欧洲正在迅速采用人工智慧驱动的医疗创新技术，以改善患者预后并提高营运效率。此外，德国、英国和法国等国家在数位化医疗的推广应用方面发挥着主导作用，这得益于其国家数位化策略和促进远距监护技术应用的报销机制。随着欧洲各地的医疗系统不断向价值医疗转型，人工智慧与远端患者监护的融合有望成为该地区现代医疗服务的基础。

亚太地区远端患者监护市场人工智慧（AI）发展趋势

远端患者监护人工智慧（AI）市场的主要参与企业有哪些？

以下列出了远端患者监护人工智慧市场的主要企业，它们合计占据最大的市场份额，并主导行业趋势：

  • Medtronic
  • iRhythm Inc.
  • Koninklijke Philips NV
  • Siemens Healthineers
  • GE Healthcare
  • Apple Inc.
  • Alivecor Inc.
  • Biofourmis
  • Optum, Inc.
  • Headspace Health
  • Withings
  • NeuroRPM Inc.
  • Caretaker Medical
  • Implicity
  • Stryker
  • Biobeat
  • Zingage
  • Teton.ai
  • Athelas
  • Empatica
  • 其他的

远端患者监护人工智慧市场的竞争格局如何？

远端患者监护(RPM) 领域的人工智慧竞争格局正逐渐演变为一个中等集中度的市场。少数几家大型医疗技术公司（例如飞利浦、美敦力、西门子医疗、通用电气医疗、雅培和波士顿科学）提供种类繁多的平台和设备，而充满活力的专业Start-Ups和软体供应商则专注于细分领域的人工智慧功能（例如癫痫发作检测、非接触式生命体征监测、动态血糖监测分析和心电图解），从而解释了一个双层市场解释。大型企业凭藉其规模、监管经验和整合产品系列，赢得医院和保险公司的合约。然而，它们面临着来自小规模、更灵活的公司的快速创新，这些公司提供一流的人工智慧演算法和设备整合方案，迫使它们寻求伙伴关係、OEM 协议和白牌，而不是纯粹依靠自身发展。市场报告指出，市场正在快速扩张，复合年增长率 (CAGR) 预计也将很高，这吸引了策略买家和投资者，并巩固了资金雄厚的现有企业的优势。同时，客户对端到端解决方案的需求以及少数几家高度互通性供应商之间的整合趋势，正在推动併购和平台整合，加剧市场集中度。虽然这一趋势在演算法准确性、边缘处理和可解释性等技术创新领域催生了良性竞争，但也造成了一种商业性权力集中在少数几家企业手中的格局，这些企业控制着分销网络、电子健康记录集成和医保报销关係。监管的复杂性、数据整合的负担以及临床检验的需求构成了有利于大型企业的障碍，但敏捷的Start-Ups仍在不断赢得临床试验和智慧财产权许可协议，从而保持着生态系统的创新性和竞争力。

人工智慧（AI）在远端患者监护市场的最新发展趋势

  • 2025 年 9 月，罗氏宣布其 Accu-Chek SmartGuide CGM 系统和 mySugr 应用程式整合已获得 CE 标誌批准，该系统整合了预测性 AI 演算法，可提供长达两小时的血糖值预测和长达七小时的夜间血糖预测。
  • 2025 年 6 月，德克萨斯州韦伯县布鲁尼市引入了 OnMed CareStation远端医疗服务终端，使偏远地区的居民能够在线上咨询认证的医疗保健专业人员，并获得即时健康评估，这表明数位医疗保健正在从诊所扩展到服务不足的地区。
  • 2025 年 5 月，Tenovi LLC 推出了一款可与 RPM 平台（用于预防中风/心血管风险管理）配合使用的联网血压监测仪，该监测仪具有心律不整检测功能。
  • 2025 年 4 月，Dexcom G7 15 天连续血糖监测系统获得美国食品药物管理局(FDA)核准，可用于糖尿病成人患者，允许延长佩戴时间，并提供更丰富的数据流，以便进行下游基于人工智慧的监测分析。
  • 2025 年 1 月，Glooko 宣布其妊娠糖尿病远距监测平台 Glooko XT 已获得法国高级卫生管理局 (HAS) 和医疗设备及医疗技术评估委员会 (CNEDiMTS) 的报销核准。
  • 2025年1月，PanopticAI的创新「生命征象」应用程式获得FDA核准，标誌着人工智慧驱动的远端患者监护领域取得了重大突破。该应用程式作为医疗设备（SaMD），利用iPhone和iPad的内藏相机，采用远端光电容积脉搏波描记法（rPPG）技术提供非接触式脉搏测量。
  • BioButton 多重病人穿戴式装置和 BioDashboard 系统于 2024 年 10 月获得美国食品药物管理局(FDA) 的核准。此穿戴式装置利用人工智慧分析技术，可在家庭环境中进行远端监测。
  • 2023 年 3 月，NeuroRPM 的革命性应用 NeuroRPM Apple Watch 获得了 FDA 的批准，这是一款突破性的 AI 解决方案，用于远端监测帕金森氏症患者的运动症状（例如运动迟缓、震颤和运动障碍）。

远端患者监护市场中人工智慧（AI）的市场细分

影响分析

人工智慧驱动的创新与应用：

人工智慧驱动的远端患者监护(RPM) 创新和应用正在彻底改变患者资料的即时收集、分析和应用方式。这些创新包括先进的机器学习演算法和预测分析，用于早期检测健康状况恶化，例如心率、血糖值和呼吸模式的变化，从而实现及时的医疗干预。人工智慧驱动的可穿戴设备和非接触式设备，例如智慧型手錶、生物识别感测器和基于摄影机的系统，持续追踪生命体征，而自然语言处理 (NLP) 和聊天机器人则增强了患者参与度和医护人员之间的沟通。此外，电脑视觉技术分析面部表情和肤色以评估血氧饱和度和压力水平，数位双胞胎技术模拟个体健康状况以预测疾病进展。基于云端的人工智慧系统进一步整合来自不同来源的多模态数据，并透过自动化仪表板为临床医生提供可操作的见解。总而言之，这些由人工智慧驱动的应用正在将远距监护转变为领先、个人化和高效的医疗保健模式，从而减少患者再入院率并改善患者预后。

美国关税对远端患者监护人工智慧（AI）市场的影响分析：

美国对人工智慧远距远端患者监护征收关税的影响主要体现在这些系统所需关键组件和技术的进口成本增加。许多人工智慧远端监护设备，包括感测器、可穿戴组件、半导体和通讯模组，都来自中国大陆、台湾和韩国等国家和地区。对这些进口产品征收关税可能会增加美国製造商的生产和采购成本，减缓医疗机构的创新和应用速度。此外，对用于整合人工智慧的云端基础设施硬体和资料处理设备征收关税，可能会进一步加剧营运预算的压力。然而，这些挑战也推动了美国本土人工智慧和数位医疗Start-Ups的生产和投资，促进了本地製造业和软体开发的创新。总而言之，虽然关税会增加短期成本并增加供应链的复杂性，但它们也刺激了旨在加强国内人工智慧医疗技术生态系统的长期策略性倡议。

目录

第一章远端患者监护市场中的人工智慧（AI）简介

第二章远端患者监护市场人工智慧（AI）市场执行摘要

  • 市场概览

第三章远端患者监护市场人工智慧（AI）关键因素分析

  • 远端患者监护市场驱动因素
  • 远端患者监护市场限制与挑战
  • 人工智慧（AI）在远端患者监护的市场机会

第四章 影响分析

  • 人工智慧驱动的创新和应用
  • 美国关税的影响分析

第五章 监理分析

  • 我们
  • 欧洲
  • 日本
  • 中国

第六章 人工智慧（AI）在远端患者监护市场的应用：波特五力分析

第七章远端患者监护人工智慧（AI）市场评估

  • 按产品/服务
    • 装置
    • 软体
    • 服务
  • 透过使用
    • 心血管疾病
    • 糖尿病
    • 神经系统疾病
    • 其他的
  • 最终用户
    • 医院和诊所
    • 诊断中心
    • 居家照护
  • 按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 其他地区

第八章 竞争情势

第九章Start-Ups资金筹措与投资趋势

第十章远端患者监护市场人工智慧（AI）公司及产品概况

  • Medtronic
  • iRhythm Inc.
  • Koninklijke Philips NV
  • Siemens Healthineers
  • GE HealthCare
  • Apple Inc.
  • Alivecor Inc.
  • Biofourmis
  • Optum, Inc.
  • Headspace Health
  • Withings
  • NeuroRPM Inc.
  • Caretaker Medical
  • Implicity
  • Stryker
  • Biobeat
  • Zingage
  • Teton.ai
  • Athelas
  • Empatica

第十一章：KOL视角

第十二章计划方法

第十三章：关于 DelveInsight

第十四章 免责声明和联络我们

Product Code: DIMDCL0866

Artificial Intelligence (AI) in Remote Patient Monitoring Market Summary

  • The global artificial intelligence in remote patient monitoring market is expected to increase from USD 1,9526.51 million in 2025 to USD 13,126.80 million by 2034, reflecting strong and sustained growth.
  • The global artificial intelligence in remote patient monitoring market is growing at a CAGR of 27.13% during the forecast period from 2026 to 2034.
  • The market of artificial intelligence in remote patient monitoring is being primarily driven by the growing prevalence of chronic diseases, increasing adoption of telehealth and digital healthcare solutions, advancements in wearable and IoT-based medical devices, and increasing research collaboration and partnership activities among pharma and medical device companies.
  • The leading companies operating in the artificial intelligence in remote patient monitoring market include Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., alivecor Inc., Biofourmis, Optum, Inc., Headspace Health, Withings, NeuroRPM Inc., Caretaker Medical, Implicity, Stryker, Biobeat, Zingage, Teton.ai, Athelas, Empatica, and others.
  • North America is expected to dominate the overall artificial intelligence in remote patient monitoring market in 2025. This dominance can be attributed to several key factors, including the rising prevalence of chronic diseases such as cancer and cardiovascular disorders, a robust healthcare infrastructure, widespread adoption of digital health technologies, and supportive government policies. Additionally, the substantial investments in digital health initiatives, coupled with the increasing adoption of wearable and connected medical devices, have further strengthened the region's readiness for AI-enabled RPM solutions, ultimately contributing to the growth of the AI in remote patient monitoring market in North America during the forecast period from 2026 to 2034.
  • In the product type segment of the artificial intelligence in remote patient monitoring market, the devices category is estimated to account for the largest market share in 2025.

Factors Contributing to the Growth of the Artificial Intelligence (AI) in Remote Patient Monitoring Market

  • Growing prevalence of chronic diseases leading to a surge in artificial intelligence in remote patient monitoring: The growing global burden of chronic conditions such as diabetes, cardiovascular diseases, hypertension, and COPD is a key driver for AI in RPM. Continuous monitoring enabled by AI algorithms allows early detection of complications and proactive disease management. AI models analyze large amounts of health data to predict exacerbations or medical emergencies, thereby reducing hospital readmissions and improving outcomes.
  • Increasing adoption of telehealth and digital healthcare solutions: The shift toward telemedicine and virtual healthcare, accelerated more by the COVID-19 pandemic, has significantly boosted the adoption of AI in RPM. AI technologies enhance the capabilities of telehealth platforms by providing real-time patient analytics, automated alerts, and remote diagnostics. This integration ensures better patient engagement and continuity of care beyond traditional hospital settings.
  • Advancements in wearable and IoT-based medical devices: The proliferation of smart wearables and connected health devices, such as ECG monitors, glucose trackers, and biosensors, generates vast amounts of patient data. AI plays a critical role in interpreting this data, identifying abnormal patterns, and offering clinical insights. The increasing accuracy and affordability of IoT-enabled devices are enhancing the scalability of AI-driven remote patient monitoring solutions.

Artificial Intelligence (AI) in Remote Patient Monitoring Market Report Segmentation

This artificial intelligence in remote patient monitoring market report offers a comprehensive overview of the global artificial intelligence in remote patient monitoring market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product & Services (Devices, Software, and Services), Application (Cardiovascular Disorder, Diabetes, Neurological Disorders, and Others), End-Users (Hospitals & Clinics, Diagnostic Centers, and Homecare Setting), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing artificial intelligence in remote patient monitoring market.

Artificial Intelligence (AI) in Remote Patient Monitoring (RPM) refers to the integration of AI technologies with remote healthcare monitoring systems to continuously track, analyze, and interpret patient health data outside traditional clinical settings. By leveraging machine learning, predictive analytics, and other AI algorithms, these systems can detect anomalies, predict potential health risks, and provide actionable insights to healthcare providers in real time. This enables proactive management of chronic conditions, personalized care, and improved patient outcomes while reducing hospital visits and healthcare costs.

The Artificial Intelligence (AI) in remote patient monitoring (RPM) market is experiencing robust growth, fueled by the rising cases of chronic conditions such as cancer, cardiovascular diseases, and lifestyle-related disorders. This growth is further supported by a surge in product development initiatives, increasing global investments in digital health infrastructure, and a growing emphasis on proactive, data-driven healthcare. These factors are expected to drive significant expansion of the AI-powered remote patient monitoring market during the forecast period from 2026 to 2034.

What are the latest Artificial Intelligence (AI) in Remote Patient Monitoring market dynamics and trends?

The global market for artificial intelligence in remote patient monitoring has witnessed significant growth in recent years, largely driven by the increasing prevalence of chronic disorders such as cancer, diabetes, cardiovascular disorders, and respiratory conditions. Additionally, the growing trend of strategic collaborations and partnerships among pharmaceutical, biotechnology, and medical device companies is playing a crucial role in accelerating the adoption of AI-powered remote patient monitoring devices.

Artificial Intelligence (AI) in Remote Patient Monitoring Market Segment Analysis

Artificial Intelligence (AI) in Remote Patient Monitoring Market by Product & Services (Devices, Software, and Services), Application (Cardiovascular Disorder, Diabetes, Neurological Disorders, and Others), End-Users (Hospitals & Clinics, Diagnostic Centers, and Homecare Setting), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Artificial Intelligence (AI) in Remote Patient Monitoring Market Regional Analysis

North America Artificial Intelligence (AI) in Remote Patient Monitoring Market Trends

North America is projected to dominate the AI in clinical trial market in 2025, accounting for approximately 47% of the total share. The growth of the Artificial Intelligence (AI) in remote patient monitoring market in the region is being driven by a combination of factors, including the rising prevalence of chronic diseases such as cancer and cardiovascular disorders, a robust healthcare infrastructure, widespread adoption of digital health technologies, and supportive government policies. Additionally, the substantial investments in digital health initiatives, coupled with the increasing adoption of wearable and connected medical devices, have further strengthened the region's readiness for AI-enabled RPM solutions.

According to the American Heart Association (2024), approximately 9.7 million adults were living with undiagnosed diabetes in the United States. Furthermore, 115.9 million people in the U.S were reported to be dealing with pre-diabetes.

Additionally, according to an article published by the CDC (2024), approximately 6.2 million adults were suffering from heart failure in the US. The same source further stated that around 20.5 million individuals were living with coronary heart disease. Furthermore, an estimated 6.5 million individuals aged 40 and older were diagnosed with peripheral artery disease (PAD) in the same year.

Patients with these chronic conditions require frequent monitoring of parameters such as blood glucose levels, heart rate, blood pressure, and ECG data, all of which can be effectively tracked using AI-integrated RPM devices. AI algorithms analyze real-time patient data to detect anomalies, predict potential complications, and provide timely alerts to healthcare providers, thereby reducing hospitalizations and improving patient outcomes. For instance, AI-enabled continuous glucose monitors (CGMs) and smart cardiac patches are helping clinicians make informed treatment decisions remotely. As healthcare systems shift toward preventive and personalized care, the ability of AI-driven RPM solutions to offer continuous, predictive, and cost-efficient management for diabetes and cardiovascular diseases is fueling their widespread adoption and propelling overall market growth.

Moreover, leading industry players in North America are actively involved in product development activities. For example, in January 2025, PanopticAI received FDA clearance for its innovative "Vital Signs" app, marking a major advancement in AI-powered remote patient monitoring. The app functions as a Software as a Medical Device (SaMD) and leverages the built-in camera of iPhones and iPads to perform contactless pulse rate measurement using remote photoplethysmography (rPPG) technology. This breakthrough enables users and healthcare providers to measure vital signs accurately without the need for physical contact or wearable devices, making it ideal for telehealth, chronic disease management, and remote care applications. The FDA approval highlights the growing acceptance of AI-driven, camera-based health monitoring tools, which enhance accessibility, convenience, and scalability in patient monitoring systems, particularly in home and outpatient settings.

Hence, all the above-mentioned factors are anticipated to register significant growth during the forecast period from 2026 to 2034 in the AI in remote patient monitoring market.

Europe Artificial Intelligence (AI) in Remote Patient Monitoring Market Trends

The Artificial Intelligence (AI) in Remote Patient Monitoring (RPM) market in Europe is witnessing robust growth, fueled by the region's strong emphasis on digital healthcare transformation, aging population, and rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and respiratory conditions. European healthcare systems are increasingly integrating AI-driven monitoring tools to enable proactive and continuous care delivery, particularly within home healthcare and telemedicine settings. The European Union's supportive policies, such as the EU4Health Program and Digital Europe initiatives, are fostering the adoption of advanced AI technologies to enhance healthcare efficiency and reduce the burden on hospital infrastructure. Moreover, AI-based RPM solutions are helping healthcare providers analyze real-time patient data, detect early signs of deterioration, and personalize treatment plans, leading to better clinical outcomes and cost savings.

A notable example underscoring this trend came in July 2025, when Siemens Healthineers launched its AI-powered remote patient monitoring platform across European hospitals, designed to detect early signs of cardiovascular and respiratory distress using predictive analytics and continuous data insights. This development demonstrates how Europe is rapidly embracing AI-enabled healthcare innovations to improve patient outcomes and operational efficiency. Additionally, countries like Germany, the UK, and France are leading in digital health adoption, supported by national digitalization strategies and reimbursement frameworks that encourage the use of remote monitoring technologies. As healthcare systems across Europe continue to transition toward value-based care, the integration of AI in remote patient monitoring is expected to become a cornerstone of modern healthcare delivery in the region.

Asia-Pacific Artificial Intelligence (AI) in Remote Patient Monitoring Market Trends

Who are the major players in the Artificial Intelligence (AI) in Remote Patient Monitoring market?

The following are the leading companies in the artificial intelligence in remote patient monitoring market. These companies collectively hold the largest market share and dictate industry trends.

  • Medtronic
  • iRhythm Inc.
  • Koninklijke Philips N.V.
  • Siemens Healthineers
  • GE Healthcare
  • Apple Inc.
  • Alivecor Inc.
  • Biofourmis
  • Optum, Inc.
  • Headspace Health
  • Withings
  • NeuroRPM Inc.
  • Caretaker Medical
  • Implicity
  • Stryker
  • Biobeat
  • Zingage
  • Teton.ai
  • Athelas
  • Empatica
  • Others

How is the competitive landscape shaping the artificial intelligence in remote patient monitoring market?

The competitive landscape for AI in Remote Patient Monitoring (RPM) is evolving into a moderately concentrated market: a handful of large medtech incumbents (Philips, Medtronic, Siemens Healthineers, GE Health Care, Abbott, Boston Scientific, etc.) lead broad platform and device offerings, while a vibrant set of specialized startups and software vendors focus on niche AI capabilities (seizure detection, contactless vitals, CGM analytics, ECG interpretation), creating a two-tier market structure. Major established players leverage scale, regulatory experience, and integrated product portfolios to win hospital and payer contracts, but they face fast innovation coming from smaller, agile firms that supply best-in-class AI algorithms and device integrations, forcing partnerships, OEM deals, and white-labeling rather than purely organic expansion. Market reports show rapid market expansion and strong projected CAGRs, which attract both strategic buyers and investors and reinforce the dominance of well-funded incumbents. At the same time, deal activity and consolidation are rising as customers demand end-to-end solutions and fewer, more interoperable vendors driving M&A and platform rollups that increase concentration over time. This dynamic produces healthy competition on innovation (algorithm accuracy, edge processing, explainability) while concentrating commercial power among a moderate number of integrators who control distribution, EHR integrations, and reimbursement relationships. Regulatory complexity, data-integration burdens, and the need for clinical validation create barriers that advantage larger firms, but nimble startups continue to win clinical pilots and IP licensing deals, keeping the ecosystem innovative and contested.

Recent Developmental Activities in the Artificial Intelligence (AI) in Remote Patient Monitoring Market

  • In September 2025, Roche announced CE-mark approval for the integration of its Accu-Chek SmartGuide CGM system with its mySugr app, incorporating predictive AI algorithms that forecast glucose levels up to two hours ahead and overnight for up to seven hours.
  • In June 2025, Bruni, Texas, in Webb County, launched an OnMed CareStation telehealth kiosk that enables residents in a remote community to consult virtually with licensed clinicians and undergo real-time health assessments, thereby illustrating how digital care is extending beyond clinics into underserved areas.
  • In May 2025, Tenovi LLC launched a connected blood pressure monitor integrated with their RPM platform (for stroke prevention / cardiovascular risk) with irregular heartbeat detection.
  • In April 2025, the Dexcom G7 15-Day Continuous Glucose Monitoring System was cleared by the U.S. Food and Drug Administration (FDA) for adults with diabetes, enhancing wear time and enabling richer data streams for downstream AI-based monitoring analytics.
  • In January 2025, Glooko, Inc. announced that the Glooko XT platform (remote monitoring of gestational diabetes) obtained reimbursement approval in France via the Haute Autorite de Sante (HAS) / Commission Nationale d'Evaluation des Dispositifs Medicaux et des Technologies de Sante (CNEDiMTS).
  • In January 2025, PanopticAI received FDA clearance for its innovative "Vital Signs" app, marking a major advancement in AI-powered remote patient monitoring. The app functions as a Software as a Medical Device (SaMD) and leverages the built-in camera of iPhones and iPads to perform contactless pulse rate measurement using remote photoplethysmography (rPPG) technology.
  • In October 2024, the BioButton Multi-Patient wearable + BioDashboard system received US Food and Drug Administration (FDA) approval. This wearable device extends remote monitoring into home settings supported by AI analytics.
  • In March 2023, NeuroRPM Inc. received FDA clearance for its innovative NeuroRPM Apple Watch application, a groundbreaking AI-powered solution designed to remotely monitor key motor symptoms in patients with Parkinson's disease, including bradykinesia, tremor, and dyskinesia.

Artificial Intelligence (AI) in Remote Patient Monitoring Market Segmentation

  • Artificial Intelligence (AI) in Remote Patient Monitoring by Product & Services Exposure
  • Devices
  • Software
  • Services
  • Artificial Intelligence (AI) in Remote Patient Monitoring Application Exposure
  • Cardiovascular Disorder
  • Diabetes
  • Neurological Disorders
  • Others
  • Artificial Intelligence (AI) in Remote Patient Monitoring End-Users Exposure
  • Hospitals and Clinics
  • Diagnostic Centers
  • Homecare Settings
  • Artificial Intelligence (AI) in Remote Patient Monitoring Geography Exposure
  • North America Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • United States Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Canada Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Mexico Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Europe Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • United Kingdom Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Germany Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • France Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Italy Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Spain Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Rest of Europe Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Asia-Pacific Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • China Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Japan Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • India Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Australia Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • South Korea Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Rest of Asia-Pacific Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Rest of the World Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • South America Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Middle East Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Africa Artificial Intelligence (AI) in Remote Patient Monitoring Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations and applications in AI-enabled remote patient monitoring (RPM) are revolutionizing how patient data is collected, analyzed, and acted upon in real time. These innovations include advanced machine learning algorithms and predictive analytics that enable early detection of health deterioration, such as changes in heart rate, glucose levels, or respiratory patterns, allowing timely medical intervention. AI-powered wearable and non-contact devices like smartwatches, biosensors, and camera-based systems-continuously track vital signs, while natural language processing (NLP) and chatbots enhance patient engagement and communication between patients and healthcare providers. Additionally, computer vision technologies analyze facial cues and skin tone to assess oxygen saturation or stress, while digital twins simulate individual health profiles to predict disease progression. Cloud-based AI systems further integrate multi-modal data from diverse sources, offering clinicians actionable insights through automated dashboards. Collectively, these AI-driven applications are transforming remote monitoring into a proactive, personalized, and efficient healthcare model that reduces hospital readmissions and improves patient outcomes.

U.S. Tariff Impact Analysis on Artificial Intelligence (AI) in Remote Patient Monitoring Market:

The U.S. tariff impact on AI-enabled remote patient monitoring primarily revolves around the increased cost of importing essential components and technologies used in these systems. Many AI-powered remote monitoring devices, such as sensors, wearable components, semiconductors, and communication modules, are sourced from countries like China, Taiwan, and South Korea. Tariffs imposed on these imports can raise production and procurement costs for U.S. manufacturers, potentially slowing innovation and adoption rates in healthcare facilities. Additionally, tariffs on cloud infrastructure hardware and data processing equipment used in AI integration may further strain operational budgets. However, these challenges have also encouraged domestic production and investment in U.S.-based AI and digital health startups, driving innovation in local manufacturing and software development. Overall, while tariffs increase short-term costs and supply chain complexities, they also stimulate long-term strategic initiatives aimed at strengthening the domestic ecosystem for AI-enabled healthcare technologies.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the Artificial Intelligence (AI) in Remote Patient Monitoring market report study

  • Market size analysis for the current artificial intelligence in remote patient monitoring market size (2025), and market forecast for 8 years (2026 to 2034)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the artificial intelligence in remote patient monitoring market.
  • Various opportunities available for the other competitors in the artificial intelligence in remote patient monitoring market space.
  • What are the top-performing segments in 2025? How these segments will perform in 2034?
  • Which are the top-performing regions and countries in the current artificial intelligence in remote patient monitoring market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the artificial intelligence in remote patient monitoring market growth in the future?

Frequently Asked Questions for the Artificial Intelligence (AI) in Remote Patient Monitoring Market

1. What is the growth rate of the artificial intelligence in remote patient monitoring market?

  • The artificial intelligence in remote patient monitoring market is estimated to grow at a CAGR of 27.13% during the forecast period from 2026 to 2034.

2. What is the market for artificial intelligence in remote patient monitoring?

  • The global artificial intelligence in remote patient monitoring market is expected to increase from USD 1,9526.51 million in 2025 to USD 13,126.80 million by 2034.

3. Which region has the highest share in the artificial intelligence in remote patient monitoring market?

  • North America is expected to dominate the overall artificial intelligence in remote patient monitoring market in 2025. The growth of the Artificial Intelligence (AI) in remote patient monitoring market in the region is being driven by a combination of factors, including the rising prevalence of chronic diseases such as cancer and cardiovascular disorders, a robust healthcare infrastructure, widespread adoption of digital health technologies, and supportive government policies. Additionally, the substantial investments in digital health initiatives, coupled with the increasing adoption of wearable and connected medical devices, have further strengthened the region's readiness for AI-enabled RPM solutions.

4. What are the drivers for the artificial intelligence in remote patient monitoring market?

  • The Artificial Intelligence (AI) in remote patient monitoring (RPM) market is experiencing robust growth, fueled by the rising cases of chronic conditions such as cancer, cardiovascular diseases, and lifestyle-related disorders. This growth is further supported by a surge in product development initiatives, increasing global investments in digital health infrastructure, and a growing emphasis on proactive, data-driven healthcare. These factors are expected to drive significant expansion of the AI-powered remote patient monitoring market during the forecast period from 2026 to 2034.

5. Who are the key players operating in the Artificial Intelligence (AI) in Remote Patient Monitoring market?

  • Some of the key market players operating in the Artificial Intelligence (AI) in Remote Patient Monitoring market include Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., alivecor Inc., Biofourmis, Optum, Inc., Headspace Health, Withings, NeuroRPM Inc., Caretaker Medical, Implicity, Stryker, Biobeat, Zingage, Teton.ai, Athelas, Empatica, and others.

Table of Contents

1. Artificial Intelligence (AI) in Remote Patient Monitoring Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Artificial Intelligence (AI) in Remote Patient Monitoring Market Executive Summary

  • 2.1 Market at Glance

3. Artificial Intelligence (AI) in Remote Patient Monitoring Market Key Factors Analysis

  • 3.1 Artificial Intelligence (AI) in Remote Patient Monitoring Market Drivers
    • 3.1.1 The growing prevalence of chronic diseases
    • 3.1.2 Increasing adoption of telehealth and digital healthcare solutions
    • 3.1.3 Advancements in wearable and IoT-based medical devices
  • 3.2 Artificial Intelligence (AI) in Remote Patient Monitoring Market Restraints and Challenges
    • 3.2.1 Concerns regarding patient data & privacy
    • 3.2.2 Stringent regulations and complexities in Artificial Intelligence (AI) integration
  • 3.3 Artificial Intelligence (AI) in Remote Patient Monitoring Market Opportunity
    • 3.3.1 Strategic business partnerships between AI startups and healthcare giants

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Artificial Intelligence (AI) in Remote Patient Monitoring Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Artificial Intelligence (AI) in Remote Patient Monitoring Market Assessment

  • 7.1 By Product & Services
    • 7.1.1 Device
    • 7.1.2 Software
    • 7.1.3 Services
  • 7.2 By Application
    • 7.2.1 Cardiovascular Disorder
    • 7.2.2 Diabetes
    • 7.2.3 Neurological Disorders
    • 7.2.4 Others
  • 7.3 By End-Users
    • 7.3.1 Hospitals and Clinics
    • 7.3.2 Diagnostic Centers
    • 7.3.3 Homecare Settings
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.1.2 Canada Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.1.3 Mexico Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
    • 7.4.2 Europe
      • 7.4.2.1 France Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.2.2 Germany Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.2.3 United Kingdom Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.2.4 Italy Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.2.5 Spain Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.2.6 Rest of Europe Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.3.2 Japan Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.3.3 India Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.3.4 Australia Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.3.5 South Korea Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.3.6 Rest of Asia-Pacific Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 Middle East Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.4.2 Africa Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.4.3 South America Artificial Intelligence (AI) in Remote Patient Monitoring Market Size In USD Million (2023-2034)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Artificial Intelligence (AI) in Remote Patient Monitoring Market Company and Product Profiles

  • 10.1 Medtronic
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 iRhythm Inc.
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Koninklijke Philips N.V.
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Siemens Healthineers
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 GE HealthCare
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Apple Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Alivecor Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Biofourmis
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Optum, Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 Headspace Health
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 Withings
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 NeuroRPM Inc.
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 Caretaker Medical
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 Implicity
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 Stryker
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 Biobeat
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 Zingage
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Teton.ai
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Athelas
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 Empatica
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global (2023-2034)
  • Table 2: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by Product & Services (2023-2034)
  • Table 3: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by Application (2023-2034)
  • Table 4: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by End-Users (2023-2034)
  • Table 5: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by Geography (2023-2034)
  • Table 6: Artificial Intelligence (AI) in Remote Patient Monitoring Market in North America (2023-2034)
  • Table 7: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the United States (2023-2034)
  • Table 8: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Canada (2023-2034)
  • Table 9: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Mexico (2023-2034)
  • Table 10: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Europe (2023-2034)
  • Table 11: Artificial Intelligence (AI) in Remote Patient Monitoring Market in France (2023-2034)
  • Table 12: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Germany (2023-2034)
  • Table 13: Artificial Intelligence (AI) in Remote Patient Monitoring Market in United Kingdom (2023-2034)
  • Table 14: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Italy (2023-2034)
  • Table 15: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Spain (2023-2034)
  • Table 16: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the Rest of Europe (2023-2034)
  • Table 17: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Asia-Pacific (2023-2034)
  • Table 18: Artificial Intelligence (AI) in Remote Patient Monitoring Market in China (2023-2034)
  • Table 19: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Japan (2023-2034)
  • Table 20: Artificial Intelligence (AI) in Remote Patient Monitoring Market in India (2023-2034)
  • Table 21: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Australia (2023-2034)
  • Table 22: Artificial Intelligence (AI) in Remote Patient Monitoring Market in South Korea (2023-2034)
  • Table 23: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Rest of Asia-Pacific (2023-2034)
  • Table 24: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the Rest of the World (2023-2034)
  • Table 25: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the Middle East (2023-2034)
  • Table 26: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Africa (2023-2034)
  • Table 27: Artificial Intelligence (AI) in Remote Patient Monitoring Market in South America (2023-2034)
  • Table 28: Competitive Landscape
  • Table 29: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Artificial Intelligence (AI) in Remote Patient Monitoring Market Drivers
  • Figure 2: Artificial Intelligence (AI) in Remote Patient Monitoring Market Restraints
  • Figure 3: Artificial Intelligence (AI) in Remote Patient Monitoring Market Opportunities
  • Figure 4: AI-Powered Innovations in Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Figure 5: US Tariff Impact on Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global (2023-2034)
  • Figure 10: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by Product & Services (2023-2034)
  • Figure 11: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by Application (2023-2034)
  • Figure 12: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by End-Users (2023-2034)
  • Figure 13: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by Geography (2023-2034)
  • Figure 14: Artificial Intelligence (AI) in Remote Patient Monitoring Market in North America (2023-2034)
  • Figure 15: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the United States (2023-2034)
  • Figure 16: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Canada (2023-2034)
  • Figure 17: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Mexico (2023-2034)
  • Figure 18: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Europe (2023-2034)
  • Figure 19: Artificial Intelligence (AI) in Remote Patient Monitoring Market in France (2023-2034)
  • Figure 20: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Germany (2023-2034)
  • Figure 21: Artificial Intelligence (AI) in Remote Patient Monitoring Market in United Kingdom (2023-2034)
  • Figure 22: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Italy (2023-2034)
  • Figure 23: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Spain (2023-2034)
  • Figure 24: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the Rest of Europe (2023-2034)
  • Figure 25: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Asia-Pacific (2023-2034)
  • Figure 26: Artificial Intelligence (AI) in Remote Patient Monitoring Market in China (2023-2034)
  • Figure 27: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Japan (2023-2034)
  • Figure 28: Artificial Intelligence (AI) in Remote Patient Monitoring Market in India (2023-2034)
  • Figure 29: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Australia (2023-2034)
  • Figure 30: Artificial Intelligence (AI) in Remote Patient Monitoring Market in South Korea (2023-2034)
  • Figure 31: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Rest of Asia-Pacific (2023-2034)
  • Figure 32: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the Rest of the World (2023-2034)
  • Figure 33: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the Middle East (2023-2034)
  • Figure 34: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Africa (2023-2034)
  • Figure 35: Artificial Intelligence (AI) in Remote Patient Monitoring Market in South America (2023-2034)
  • Figure 36: Competitive Landscape
  • Figure 37: Startup Funding & Investment Trends